Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Frequent budget adjustments help you respond to income shifts and spending surprises. This intro guides quick, practical tweaks for staying on track.
26,559 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Investors are eyeing Life Time's Q4 2025 earnings to gauge membership momentum, pricing discipline, and growth strate...
As AI data centers ramp up, two independent power producers headline the market: Constellation Energy and Vistra. Thi...
A major investor moved a sizable stake in Hinge Health, triggering questions about timing and motives. This analysis ...
Oxbridge Re kicks off 2026 with a Q1 that mixes solid underwriting with measured investment moves. This deep dive exp...
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Britain’s central bank shifts how stablecoins are regulated, removing strict per-coin caps and allowing larger reserv...
Henry Hub natural gas vaulted to $7.72 in January before tumbling to $3.62 in February, forcing traders to pick sides...
A tech-led rally has spotlighted triple-leveraged ETFs, sparking debate on long-run viability. This piece explains ho...
Healthcare megacaps Pfizer and Johnson & Johnson continue to deliver quarterly dividends that can generate reliable i...
SpaceX is inching toward a public listing that could expose who truly owns private stakes and how that ownership tran...
As AI models scale, the memory layer becomes the bottleneck that can shape profits. This piece explains why sandisk (...